LAS VEGAS — Zepto is an “innovative disposable device” that utilizes “precision pulsed technology” to create capsulotomies and shows promise in adoption by cataract surgeons when it comes to market, according to the company’s senior executive.John Hendrick, president and CEO of Mynosys Cellular Devices, told colleagues at the Ophthalmology Innovation Summit here that “for many months and years,” the company has been focusing on being able to create “a perfectly round capsulotomy, every time.”
Uncategorized